User menu

Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014).

Bibliographic reference Ceyssens, Pieter-Jan ; Van Bambeke, Françoise ; Mattheus, Wesley ; Bertrand, Sophie ; Fux, Frédéric ; et. al. Molecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014).. In: PLoS One, Vol. 11, no. 5, p. e0154816 [1-17] (2016)
Permanent URL
  1. Bridy-Pappas Angela E., Margolis Marya B., Center Kimberly J., Isaacman Daniel J., Streptococcus pneumoniae: Description of the Pathogen, Disease Epidemiology, Treatment, and Prevention, 10.1592/phco.2005.25.9.1193
  2. Liñares J., Ardanuy C., Pallares R., Fenoll A., Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period, 10.1111/j.1469-0691.2010.03182.x
  3. Adam Heather J., Hoban Daryl J., Gin Alfred S., Zhanel George G., Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997–2006, 10.1016/j.ijantimicag.2009.02.002
  4. Zhanel George G., Ennis Kelly, Vercaigne Lavern, Walkty Andrew, Gin Alfred S., Embil John, Smith Heather, Hoban Daryl J., A Critical Review of the Fluoroquinolones : Focus on Respiratory Infections, 10.2165/00003495-200262010-00002
  5. Hooper David C., Mode of Action of Fluoroquinolones : , 10.2165/00003495-199958002-00002
  6. C Janoir, Antimicrob Agents Chemother, 40, 2760 (1996)
  7. JH Jorgensen, Antimicrob Agents Chemother, 43, 329 (1999)
  8. Jones M. E., Sahm D. F., Martin N., Scheuring S., Heisig P., Thornsberry C., Kohrer K., Schmitz F.-J., Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season, 10.1128/aac.44.2.462-466.2000
  9. Patel Samir N, Melano Roberto, McGeer Allison, Green Karen, Low Donald E, Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada, 10.1186/1476-0711-9-3
  10. Li X., Zhao X., Drlica K., Selection of Streptococcus pneumoniae Mutants Having Reduced Susceptibility to Moxifloxacin and Levofloxacin, 10.1128/aac.46.2.522-524.2002
  11. Smith H. J., Walters M., Hisanaga T., Zhanel G. G., Hoban D. J., Mutant Prevention Concentrations for Single-Step Fluoroquinolone-Resistant Mutants of Wild-Type, Efflux-Positive, or ParC or GyrA Mutation-Containing Streptococcus pneumoniae Isolates, 10.1128/aac.48.10.3954-3958.2004
  12. Maeda Y., Murayama M., Goldsmith C. E., Coulter W. A., Mason C., Millar B. C., Dooley J. S. G., Lowery C. J., Matsuda M., Rendall J. C., Elborn J. S., Moore J. E., Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis, 10.1093/jac/dkq485
  13. Jumbe N. L., Louie A., Miller M. H., Liu W., Deziel M. R., Tam V. H., Bachhawat R., Drusano G. L., Quinolone Efflux Pumps Play a Central Role in Emergence of Fluoroquinolone Resistance in Streptococcus pneumoniae, 10.1128/aac.50.1.310-317.2006
  14. MJ Gill, Antimicrob Agents Chemother, 43, 187 (1999)
  15. Piddock L. J. V., Johnson M. M., Simjee S., Pumbwe L., Expression of Efflux Pump Gene pmrA in Fluoroquinolone-Resistant and -Susceptible Clinical Isolates of Streptococcus pneumoniae, 10.1128/aac.46.3.808-812.2002
  16. Garvey M. I., Baylay A. J., Wong R. L., Piddock L. J. V., Overexpression of patA and patB, Which Encode ABC Transporters, Is Associated with Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae, 10.1128/aac.00672-10
  17. Garvey M. I., Piddock L. J. V., The Efflux Pump Inhibitor Reserpine Selects Multidrug-Resistant Streptococcus pneumoniae Strains That Overexpress the ABC Transporters PatA and PatB, 10.1128/aac.01644-07
  18. El Garch Farid, Lismond Ann, Piddock Laura J. V., Courvalin Patrice, Tulkens Paul M., Van Bambeke Françoise, Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae, 10.1093/jac/dkq287
  19. Avrain L., Garvey M., Mesaros N., Glupczynski Y., Mingeot-Leclercq M.-P., Piddock L. J. V., Tulkens P. M., Vanhoof R., Van Bambeke F., Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations, 10.1093/jac/dkm292
  20. Robertson G. T., Doyle T. B., Lynch A. S., Use of an Efflux-Deficient Streptococcus pneumoniae Strain Panel To Identify ABC-Class Multidrug Transporters Involved in Intrinsic Resistance to Antimicrobial Agents, 10.1128/aac.49.11.4781-4783.2005
  21. Baylay Alison J., Ivens Alasdair, Piddock Laura J. V., A Novel Gene Amplification Causes Upregulation of the PatAB ABC Transporter and Fluoroquinolone Resistance in Streptococcus pneumoniae, 10.1128/aac.04858-14
  22. Baylay A. J., Piddock L. J. V., Clinically relevant fluoroquinolone resistance due to constitutive overexpression of the PatAB ABC transporter in Streptococcus pneumoniae is conferred by disruption of a transcriptional attenuator, 10.1093/jac/dku449
  23. A Lupien, J Antimicrob Chemother, 70, 1946 (2015)
  24. Lupien A., Billal D. S., Fani F., Soualhine H., Zhanel G. G., Leprohon P., Ouellette M., Genomic Characterization of Ciprofloxacin Resistance in a Laboratory-Derived Mutant and a Clinical Isolate of Streptococcus pneumoniae, 10.1128/aac.00418-13
  25. Said Maria A., Johnson Hope L., Nonyane Bareng A. S., Deloria-Knoll Maria, O′Brien Katherine L., , Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques, 10.1371/journal.pone.0060273
  26. K Ubukata, J Clin Microbiol, 34, 592 (1996)
  27. Elberse Karin E. M., van de Pol Ingrid, Witteveen Sandra, van der Heide Han G. J., Schot Corrie S., van Dijk Anita, van der Ende Arie, Schouls Leo M., Population Structure of Invasive Streptococcus pneumoniae in the Netherlands in the Pre-Vaccination Era Assessed by MLVA and Capsular Sequence Typing, 10.1371/journal.pone.0020390
  28. Blondeau J.M, Vaughan D, Laskowski R, Borsos S, Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents, 10.1016/s0924-8579(01)00334-x
  29. Firsov Alexander A., Alferova Irene V., Smirnova Maria V., Lubenko Irene Yu., Portnoy Yury A., Zinner Stephen H., Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model, 10.1016/j.ijantimicag.2005.02.004
  30. MW Pfaffl, 87 (2004)
  31. Dang Trang Nguyen Doan, Srinivasan Usha, Britt Zachary, Marrs Carl F., Zhang Lixin, Ki Moran, Foxman Betsy, Efflux-mediated Resistance Identified Among Norfloxacin Resistant Clinical Strains of Group B Streptococcus From South Korea, 10.4178/epih/e2014022
  32. Kaatz G. W., Seo S. M., O'Brien L., Wahiduzzaman M., Foster T. J., Evidence for the Existence of a Multidrug Efflux Transporter Distinct from NorA in Staphylococcus aureus, 10.1128/aac.44.5.1404-1406.2000
  33. Johnson Alan P., Warner Marina, Livermore David M., Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom, 10.1093/jac/45.2.225
  34. Tubau F., Fernandez-Roblas R., Linares J., Martin R., Soriano F., In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods, 10.1093/jac/47.5.675
  35. Riedel S., Neoh K. M., Eisinger S. W., Dam L. M., Tekle T., Carroll K. C., Comparison of Commercial Antimicrobial Susceptibility Test Methods for Testing of Staphylococcus aureus and Enterococci against Vancomycin, Daptomycin, and Linezolid, 10.1128/jcm.00957-14
  36. Boncoeur Emilie, Durmort Claire, Bernay Benoît, Ebel Christine, Di Guilmi Anne Marie, Croizé Jacques, Vernet Thierry, Jault Jean-Michel, PatA and PatB Form a Functional Heterodimeric ABC Multidrug Efflux Transporter Responsible for the Resistance ofStreptococcus pneumoniaeto Fluoroquinolones, 10.1021/bi300762p
  37. Wang Y. C., Lipsitch M., Upgrading antibiotic use within a class: Tradeoff between resistance and treatment success, 10.1073/pnas.0600636103
  38. Bowker K. E., Garvey M. I., Noel A. R., Tomaselli S. G., MacGowan A. P., Comparative antibacterial effects of moxifloxacin and levofloxacin on Streptococcus pneumoniae strains with defined mechanisms of resistance: impact of bacterial inoculum, 10.1093/jac/dks537
  39. Zhang G., Tian W., Wang C., Feng J., Identification of a novel resistance mutation in parE that confers high-level resistance to moxifloxacin in Streptococcus pneumoniae, 10.1093/jac/dks262
  40. Zhang Gang, Wang Chao, Sui Zhihai, Feng Jie, Insights into the evolutionary trajectories of fluoroquinolone resistance inStreptococcus pneumoniae, 10.1093/jac/dkv134
  41. Guérin François, Galimand Marc, Tuambilangana Fabrice, Courvalin Patrice, Cattoir Vincent, Overexpression of the Novel MATE Fluoroquinolone Efflux Pump FepA in Listeria monocytogenes Is Driven by Inactivation of Its Local Repressor FepR, 10.1371/journal.pone.0106340
  42. Jacoby G. A., Hooper D. C., Phylogenetic Analysis of Chromosomally Determined Qnr and Related Proteins, 10.1128/aac.02080-12
  43. Tocci N., Iannelli F., Bidossi A., Ciusa M. L., Decorosi F., Viti C., Pozzi G., Ricci S., Oggioni M. R., Functional Analysis of Pneumococcal Drug Efflux Pumps Associates the MATE DinF Transporter with Quinolone Susceptibility, 10.1128/aac.01298-12
  44. Marrer E., Satoh A. T., Johnson M. M., Piddock L. J. V., Page M. G. P., Global Transcriptome Analysis of the Responses of a Fluoroquinolone-Resistant Streptococcus pneumoniae Mutant and Its Parent to Ciprofloxacin, 10.1128/aac.50.1.269-278.2006